{{Rsnum
|rsid=4837752
|Chromosome=9
|position=120294359
|Orientation=plus
|GMAF=0.1717
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 13.4 | 86.6
| HCB | 7.3 | 31.4 | 61.3
| JPT | 8.0 | 43.4 | 48.7
| YRI | 9.8 | 31.5 | 58.7
| ASW | 1.8 | 38.6 | 59.6
| CHB | 7.3 | 31.4 | 61.3
| CHD | 5.6 | 39.8 | 54.6
| GIH | 0.0 | 25.7 | 74.3
| LWK | 4.8 | 32.4 | 62.9
| MEX | 3.4 | 48.3 | 48.3
| MKK | 0.0 | 12.9 | 87.1
| TSI | 1.0 | 9.8 | 89.2
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19875103
|Trait=Response to antipsychotic therapy (extrapyramidal side effects)
|Title=Genomewide Association Study of Movement-Related Adverse Antipsychotic Effects
|RiskAllele=
|Pval=0.000006
|OR=NR
|ORtxt=NR
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4837752
|overall_frequency_n=20
|overall_frequency_d=128
|overall_frequency=0.15625
|n_genomes=18
|n_genomes_annotated=0
|n_haplomes=20
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}